ConductScience.org, home

Paper41007114

Tumor-Immune Interactions in Pediatric Oral Rhabdomyosarcoma: A Narrative Review on Immuno-Oncology and Emerging Therapies.

El Meligy OA and 3 others. Children (Basel), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Tumor-Immune Interactions in Pediatric Oral Rhabdomyosarcoma: A Narrative Review on Immuno-Oncology and Emerging Therapies. Papers, record 41007114. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007114

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-Immune Interactions in Pediatric Oral Rhabdomyosarcoma: A Narrative Review on Immuno-Oncology and Emerging Therapies.
PubMed
Journal
Children (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-09-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References167

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133816783Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.Mol Ther Oncolytics2021https://conductscience.org/library/papers/33816783PubMed
239780248Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy.Mol Cancer2025https://conductscience.org/library/papers/39780248PubMed
336009387T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders.Biomedicines2022https://conductscience.org/library/papers/36009387PubMed
440234830Myogenic IGFBP5 levels in rhabdomyosarcoma are nourished by mesenchymal stromal cells and regulate growth arrest and apoptosis.Cell Commun Signal2025https://conductscience.org/library/papers/40234830PubMed
531704149The PD-L1/PD-1 axis expression on tumor-infiltrating immune cells and tumor cells in pediatric rhabdomyosarcoma.Pathol Res Pract2019https://conductscience.org/library/papers/31704149PubMed
637132013Preclinical models for development of immune-oncology therapies.Immuno-oncol Insights2022https://conductscience.org/library/papers/37132013PubMed
734107450Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis.Eur J Cancer2021https://conductscience.org/library/papers/34107450PubMed
837854913Alveolar type of rhabdomyosarcoma of maxilla-A case report.J Oral Maxillofac Pathol2023https://conductscience.org/library/papers/37854913PubMed
934373263The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.Cancer Discov2021https://conductscience.org/library/papers/34373263PubMed
1030413827Cytokines in clinical cancer immunotherapy.Br J Cancer2019https://conductscience.org/library/papers/30413827PubMed
1135565399Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults.Cancers (Basel)2022https://conductscience.org/library/papers/35565399PubMed
1234113750Immune-Based Approaches for the Treatment of Pediatric Malignancies.Annu Rev Cancer Biol2020https://conductscience.org/library/papers/34113750PubMed
1330364635Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma.Mol Ther Oncolytics2018https://conductscience.org/library/papers/30364635PubMed
1429029499Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.Oncotarget2017https://conductscience.org/library/papers/29029499PubMed
1531794912Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications.Cancer Treat Rev2020https://conductscience.org/library/papers/31794912PubMed
1639963129CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.Front Immunol2025https://conductscience.org/library/papers/39963129PubMed
1737364231Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM.JCO Precis Oncol2023https://conductscience.org/library/papers/37364231PubMed
1829891791TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.Cancers (Basel)2018https://conductscience.org/library/papers/29891791PubMed
1933182650Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma.Cancers (Basel)2020https://conductscience.org/library/papers/33182650PubMed
2026173023IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.PLoS One2015https://conductscience.org/library/papers/26173023PubMed

See all 167 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42646677Bidirectional Interplay Between Tumor Vaccines and the Tumor Microenvironment: Mechanisms, Cold-to-Hot Conversion, and Combination Strategies.Vaccines (Basel)2026https://conductscience.org/library/papers/42646677PubMed
41984108Immunotherapy for pediatric solid tumors: overcoming biological barriers through rational multimodal combinations.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41984108PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
FOXO12308PubTator's text mininghttps://conductscience.org/library/genes/2308NCBI Gene
PAX35077PubTator's text mininghttps://conductscience.org/library/genes/5077NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007114

GET https://conductscience.org/api/papers/v1/41007114/references?page=2